Overview
McDermott intellectual property litigators are among lawyers from three firms who continue to represent Amgen Inc. as the Federal Circuit hears an appeal of a jury verdict upholding Amgen’s Repatha patents. The Federal Circuit stayed a permanent injunction order enjoining sales of Sanofi’s competing drug Praluent until it rules on the appeal.